Hope H Bauer, Melissa A Jarvis, Emily A Hoffberg, Ali F Batur, Leila S Hojat, Adonis K Hijaz, David Sheyn
{"title":"多重聚合酶链反应与标准尿培养在出现急性膀胱炎症状的妇女中的作用","authors":"Hope H Bauer, Melissa A Jarvis, Emily A Hoffberg, Ali F Batur, Leila S Hojat, Adonis K Hijaz, David Sheyn","doi":"10.1007/s00192-025-06295-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and hypothesis: </strong>Prior studies suggest that acute cystitis diagnosis using standard urine culture (SUC) may be suboptimal compared to multiplex polymerase chain reaction (mPCR). mPCR is hypothesized to deliver faster and more accurate results.</p><p><strong>Methods: </strong>This was a prospective, paired, within-subject study of female patients ≥ 60 years presenting with symptoms of acute cystitis. For all patients, urine samples were collected and SUC and mPCR results using the Vikor Urine-ID™ platform were obtained. Initial treatment was based on the results of the first available test, either SUC or mPCR. The primary outcome was time from initial presentation to correct antibiotic therapy. Secondary outcomes included patient perception of symptoms, antibiotic regimen changes, and discordance between the test results.</p><p><strong>Results: </strong>A total of 87 patients were eligible for analysis. Overall, there were 36 positive SUC (41.4%) and 71 positive mPCR (81.6%) results. Discordant results were noted in 43.7% of patients, which lead to treatment changes in 33.3% of patients. The time to correct antibiotic therapy was not significantly different based on initial treatment choice test (mPCR 67.0 h vs SUC 78.2 h, p = 0.16). However, in the case of positive SUC, the time to correct antibiotic therapy was significantly shorter for mPCR (mPCR 64.8 h vs SUC 79.5 h, p = 0.02). Non-Escherichia coli species, specifically Enterococcus faecalis, were more likely to be identified on mPCR (43.7%) than on SUC (8.3%), p < 0.001.</p><p><strong>Conclusions: </strong>mPCR may be an effective method of identifying urinary pathogens in symptomatic patients, particularly those with non-Escherichia coli species.</p>","PeriodicalId":14355,"journal":{"name":"International Urogynecology Journal","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multiplex Polymerase Chain Reaction vs Standard Urine Culture in Women Presenting with Symptoms of Acute Cystitis.\",\"authors\":\"Hope H Bauer, Melissa A Jarvis, Emily A Hoffberg, Ali F Batur, Leila S Hojat, Adonis K Hijaz, David Sheyn\",\"doi\":\"10.1007/s00192-025-06295-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction and hypothesis: </strong>Prior studies suggest that acute cystitis diagnosis using standard urine culture (SUC) may be suboptimal compared to multiplex polymerase chain reaction (mPCR). mPCR is hypothesized to deliver faster and more accurate results.</p><p><strong>Methods: </strong>This was a prospective, paired, within-subject study of female patients ≥ 60 years presenting with symptoms of acute cystitis. For all patients, urine samples were collected and SUC and mPCR results using the Vikor Urine-ID™ platform were obtained. Initial treatment was based on the results of the first available test, either SUC or mPCR. The primary outcome was time from initial presentation to correct antibiotic therapy. Secondary outcomes included patient perception of symptoms, antibiotic regimen changes, and discordance between the test results.</p><p><strong>Results: </strong>A total of 87 patients were eligible for analysis. Overall, there were 36 positive SUC (41.4%) and 71 positive mPCR (81.6%) results. Discordant results were noted in 43.7% of patients, which lead to treatment changes in 33.3% of patients. The time to correct antibiotic therapy was not significantly different based on initial treatment choice test (mPCR 67.0 h vs SUC 78.2 h, p = 0.16). However, in the case of positive SUC, the time to correct antibiotic therapy was significantly shorter for mPCR (mPCR 64.8 h vs SUC 79.5 h, p = 0.02). Non-Escherichia coli species, specifically Enterococcus faecalis, were more likely to be identified on mPCR (43.7%) than on SUC (8.3%), p < 0.001.</p><p><strong>Conclusions: </strong>mPCR may be an effective method of identifying urinary pathogens in symptomatic patients, particularly those with non-Escherichia coli species.</p>\",\"PeriodicalId\":14355,\"journal\":{\"name\":\"International Urogynecology Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Urogynecology Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00192-025-06295-8\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urogynecology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00192-025-06295-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
前言和假设:先前的研究表明,与多重聚合酶链反应(mPCR)相比,使用标准尿培养(SUC)诊断急性膀胱炎可能不是最佳的。据推测,mPCR可以提供更快、更准确的结果。方法:这是一项前瞻性、配对、受试者内研究,研究对象为年龄≥60岁、出现急性膀胱炎症状的女性患者。收集所有患者的尿液样本,使用Vikor urine - id™平台获得SUC和mPCR结果。最初的治疗是基于第一次可用的检测结果,无论是SUC还是mPCR。主要观察指标是从最初出现到正确抗生素治疗的时间。次要结局包括患者对症状的感知、抗生素治疗方案的改变以及检测结果之间的不一致。结果:共有87例患者符合分析条件。总体而言,SUC阳性36例(41.4%),mPCR阳性71例(81.6%)。43.7%的患者结果不一致,导致33.3%的患者改变治疗方案。根据初始治疗选择检验,纠正抗生素治疗的时间无显著差异(mPCR 67.0 h vs SUC 78.2 h, p = 0.16)。然而,在SUC阳性的情况下,mPCR纠正抗生素治疗的时间明显短于mPCR (64.8 h vs SUC 79.5 h, p = 0.02)。非大肠杆菌,特别是粪肠球菌,在mPCR上的检出率(43.7%)高于在SUC上的检出率(8.3%)。p结论:mPCR可能是一种有效的方法,在有症状的患者中,特别是那些非大肠杆菌的患者。
Multiplex Polymerase Chain Reaction vs Standard Urine Culture in Women Presenting with Symptoms of Acute Cystitis.
Introduction and hypothesis: Prior studies suggest that acute cystitis diagnosis using standard urine culture (SUC) may be suboptimal compared to multiplex polymerase chain reaction (mPCR). mPCR is hypothesized to deliver faster and more accurate results.
Methods: This was a prospective, paired, within-subject study of female patients ≥ 60 years presenting with symptoms of acute cystitis. For all patients, urine samples were collected and SUC and mPCR results using the Vikor Urine-ID™ platform were obtained. Initial treatment was based on the results of the first available test, either SUC or mPCR. The primary outcome was time from initial presentation to correct antibiotic therapy. Secondary outcomes included patient perception of symptoms, antibiotic regimen changes, and discordance between the test results.
Results: A total of 87 patients were eligible for analysis. Overall, there were 36 positive SUC (41.4%) and 71 positive mPCR (81.6%) results. Discordant results were noted in 43.7% of patients, which lead to treatment changes in 33.3% of patients. The time to correct antibiotic therapy was not significantly different based on initial treatment choice test (mPCR 67.0 h vs SUC 78.2 h, p = 0.16). However, in the case of positive SUC, the time to correct antibiotic therapy was significantly shorter for mPCR (mPCR 64.8 h vs SUC 79.5 h, p = 0.02). Non-Escherichia coli species, specifically Enterococcus faecalis, were more likely to be identified on mPCR (43.7%) than on SUC (8.3%), p < 0.001.
Conclusions: mPCR may be an effective method of identifying urinary pathogens in symptomatic patients, particularly those with non-Escherichia coli species.
期刊介绍:
The International Urogynecology Journal is the official journal of the International Urogynecological Association (IUGA).The International Urogynecology Journal has evolved in response to a perceived need amongst the clinicians, scientists, and researchers active in the field of urogynecology and pelvic floor disorders. Gynecologists, urologists, physiotherapists, nurses and basic scientists require regular means of communication within this field of pelvic floor dysfunction to express new ideas and research, and to review clinical practice in the diagnosis and treatment of women with disorders of the pelvic floor. This Journal has adopted the peer review process for all original contributions and will maintain high standards with regard to the research published therein. The clinical approach to urogynecology and pelvic floor disorders will be emphasized with each issue containing clinically relevant material that will be immediately applicable for clinical medicine. This publication covers all aspects of the field in an interdisciplinary fashion